# Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)

> **NCT06458010** · EARLY_PHASE1 · RECRUITING · sponsor: **RenJi Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Familial Hypercholesterolemia

## Interventions

- **DRUG:** YOLT-101

## Key facts

- **NCT ID:** NCT06458010
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-24
- **Primary completion:** 2026-01-25
- **Final completion:** 2026-01-25
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06458010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06458010, "Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06458010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*